Life Science News

New Bloom lab will support operations in the Honolulu area and surrounding region

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in in the Honolulu area.

The new location provides expanded laboratories for operational health services and diagnostic testing to meet continued demand. Bloom has also added a local team. The Honolulu location will serve film/TV productions in addition to new opportunities with local businesses and organizations in the surrounding area.

"Adding services in Honolulu shows flexibility in our business model," said Andrew Morton, CEO of Bloom. "We've shown the local market in the Hawaiian islands our willingness to bring services directly to them. The clients that brought us to Hawaii are a great baseline for Bloom to prove out a longer term model of support for health services across the United States. We continue to be focused on delivering technology enabled, operational health services to large employers."

The Company also announces that in connection with closing the second tranche of its previously announced non-brokered private placement offering (the "Offering") on July 18, 2022, total compensation paid was C$33,240 and 166,200 compensation options, and not as previously indicated. All securities issued in connection with the Offering are subject to a statutory hold period until November 19, 2022 in accordance with applicable securities laws.

About Bloom Health Partners Inc.
Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) is a global platform for healthcare security, diagnostic testing and occupational health-tech. Our mission is to ensure that "unstoppable is possible" for businesses and their employees through innovative, customized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.

For more information: info@bloomhealthpartners.com

On behalf of the board of directors,

Bloom Health Partners Inc.

Andrew Morton, Chief Executive Officer

Forward-Looking Statements

This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company's forward-looking statements include the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company's filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/137059

News Provided by Newsfile via QuoteMedia

BLMH:CNX
Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of diagnostic and health technology services, announces a leadership transition.

Effective September 30, 2022, Andrew Morton has stepped down as CEO of the Company to pursue other opportunities. Rosemary Elliston, COO of the Company, has been appointed to the position of Interim CEO. Mr. Morton will continue to support the Company as a Director.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners CEO to Speak at Health Benefits Nation Conference in Orlando

Bloom Health Partners CEO to Speak at Health Benefits Nation Conference in Orlando

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces its CEO, Andrew Morton, will speak on a panel at Health Benefits Nation Conference in Orlando, Florida on September 15th, 2022.

Mr. Morton will join co-panelists Eric Hargan, former U.S. Federal Deputy Secretary of the Department of Health and Human Services (DHHS), and Jeff Hogan, President of Upside Health Advisors. The panel titled "Incorporating Occupational Health into Value Based Health Strategies" will focus on workplace health and using data models to improve outcomes in occupational health in such areas as preventive care and mental health.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Reports Profitable Fiscal Q3 2022 with $8.4 Million in Revenue

Bloom Health Partners Reports Profitable Fiscal Q3 2022 with $8.4 Million in Revenue

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces unaudited Fiscal Q2 2022 revenues of CAD $8.4M for the three months ended June 30th, 2022, bringing year-to-date revenues to CAD $24.9M for the first three quarters of Fiscal 2022.

Highlights in Fiscal Q2 2022:

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces New Location to Serve Chicago and Surrounding Area

Bloom Health Partners Announces New Location to Serve Chicago and Surrounding Area

New Bloom lab in the Chicago area will serve as a foothold in the midwestern United States

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D84) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in the Chicago area.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces Closing of Second Tranche of Private Placement for over C$1.58M in Aggregate Gross Proceeds

Bloom Health Partners Announces Closing of Second Tranche of Private Placement for over C$1.58M in Aggregate Gross Proceeds

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces that it has closed the second tranche of its previously announced non-brokered private placement offering (the "Offering") and has issued 2,770,000 units (the "Units") at $0.20 per Unit for gross proceeds of C$554,000. Combined with the first tranche of the Offering, the Company has sold 7,920,000 Units of the Company for aggregate gross proceeds of C$1,584,000. The Units are comprised of (i) one (1) common share in the capital of the Company ("Common Shares"); and (ii) one-half (12) of a transferable common share purchase warrant (each whole warrant, a "Warrant" and collectively, the "Warrants"). Each Warrant entitles the holder thereof to acquire one (1) additional Common Share (each, a "Warrant Share") in the capital of the Company at a price of $0.30 per Warrant Share until July 18, 2023. The net proceeds of the Offering will be used by the Company for ongoing working capital and corporate development.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Graphene Manufacturing Group Announces Filing of Its Amended Annual Financial Statements for The Years Ended 30 June 2022 and 2021

Graphene Manufacturing Group Announces Filing of Its Amended Annual Financial Statements for The Years Ended 30 June 2022 and 2021

Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG" or the "Company") announces the filing of its amended audited financial statements for the years ended June 30, 2022 and 2021 (the "Amended Financial Statements") to amend the Company's audited annual statements filed on SEDAR on September 29, 2022. The Amended Financial Statements have been filed to include an unmodified auditor's report to reflect that the statements have been audited in accordance with Canadian generally accepted auditing standards, as required by NI 52-107 Acceptable Accounting Principles and Audited Standards. In addition, the Amended Financial Statements have been updated with a current date of authorization and thus changes have been made to the disclosures for going concern and subsequent events. Other than these disclosure updates, no other changes have been made to the Amended Financial Statements.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Alkaline Fuel Cell Power Corp. Announces CEO Frank Carnevale will Webcast Live at VirtualInvestorConferences.com December 1st

Alkaline Fuel Cell Power Corp. Announces CEO Frank Carnevale will Webcast Live at VirtualInvestorConferences.com December 1st

Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (" PWWR " or the " Company "), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce that PWWR's CEO, Frank Carnevale, will be giving a Company presentation live at VirtualInvestorConferences.com on December 1st, 2022.

DATE: December 1st, 2022
TIME: 12:30 – 1:00 pm EST
LINK: https://bit.ly/3WBnUTQ

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
REPEAT - Alkaline Fuel Cell Power Corp. Announces Letter of Intent for Joint Venture with AmmPower Corp. for Fuel Cell Generator Pilot Using Green Ammonia

REPEAT - Alkaline Fuel Cell Power Corp. Announces Letter of Intent for Joint Venture with AmmPower Corp. for Fuel Cell Generator Pilot Using Green Ammonia

Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (" PWWR " or the " Company "), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce that on November 3 rd 2022, the Company executed a non-binding letter of intent (the " LOI ") with AmmPower Corp. (" AmmPower "), a company developing technology to convert green ammonia into green hydrogen. The LOI summarizes the intentions of the Company and AmmPower entering into a joint venture (the " JV ") for the development of a pilot project testing PWWR's off-grid fuel cell generator and AmmPower's ammonia cracking technology (the " Pilot ").

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
dynaCERT Launches Private Placement of Carbon Credit Convertible Notes

dynaCERT Launches Private Placement of Carbon Credit Convertible Notes

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") is pleased to announce that it has launched an offering of up to $10,000,000 of Carbon Credit Convertible Notes under private placement exemptions in Canada. The offering is not convertible into the Company's common shares and is non-dilutive to shareholders of the Company.

Each Carbon Credit Convertible Note is priced at $1,000 (Canadian) with a maturity date of ten (10) years after the date of issue. Commencing at the fifth (5 th ) anniversary after the date of issue, the Carbon Credit Convertible Notes will be convertible, at any time thereafter, at the option of the holder, into Carbon Credits generated by dynaCERT's proprietary HydraGEN™ Technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Alkaline Fuel Cell Power Corp. Announces Letter of Intent for Joint Venture with AmmPower Corp. for Fuel Cell Generator Pilot Using Green Ammonia

Alkaline Fuel Cell Power Corp. Announces Letter of Intent for Joint Venture with AmmPower Corp. for Fuel Cell Generator Pilot Using Green Ammonia

Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (" PWWR " or the " Company "), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to announce that on November 3 rd 2022, the Company executed a non-binding letter of intent (the " LOI ") with AmmPower Corp. (" AmmPower "), a company developing technology to convert green ammonia into green hydrogen. The LOI summarizes the intentions of the Company and AmmPower entering into a joint venture (the " JV ") for the development of a pilot project testing PWWR's off-grid fuel cell generator and AmmPower's ammonia cracking technology (the " Pilot ").

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
REPEAT - Alkaline Fuel Cell Power Corp. Closes Convertible Note Financing

REPEAT - Alkaline Fuel Cell Power Corp. Closes Convertible Note Financing

Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (" AFCP " or the " Company "), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to the closing of a convertible note (the " Convertible Note ") financing in an aggregate amount C$4,000,000 (the " Financing ").

"We are pleased with the support of our investors for this Financing," said Frank Carnevale, Chief Executive Officer. "The Financing will assist with our working capital and allow the Company to focus on developing affordable renewable energy projects."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×